Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study

被引:4
|
作者
Unal, Gonca Ayse [1 ]
Kenar, Ayse Nur Inci [2 ]
Herken, Hasan [2 ]
Kiroglu, Yilmaz [3 ]
机构
[1] Kozan State Hosp, Psychiat Clin, Adana, Turkey
[2] Pamukkale Univ, Sch Med, Dept Psychiat, TR-20070 Denizli, Turkey
[3] Pamukkale Univ, Sch Med, Dept Radiol, TR-20070 Denizli, Turkey
关键词
Adult ADHD; Subtype; Methylphenidate; Magnetic resonance spectroscopy; UTAH RATING-SCALE; DEFICIT/HYPERACTIVITY DISORDER; MR SPECTROSCOPY; CHILDREN; GLUTAMATE/GLUTAMINE; ADOLESCENTS; VALIDITY; CREATINE;
D O I
10.1016/j.neulet.2015.08.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of methylphenidate (MPH) treatment on N-acetyl aspartate (NAA), choline and creatine are being examined in individuals with different subtypes of attention deficit hyperactivity disorder (ADHD). Sixty ADHD subjects were included into the study aging between 18 and 60 years. Levels of NAA, creatine and choline in anterior cingulate cortex, cerebellum, striatum and dorsolateral prefrontal cortex were measured with magnetic resonance spectroscopy. Then, 10 mg oral MPH was given to the subjects and the same metabolite levels were measured after an interval of 30 min. Distribution of the patients according to the ADHD subtypes was as follows: 21 of them (35.0%) were in the inattentive type, 11 of them (18.3%) were in the hyperactive type and 28 of them were (46.7%) in the combined type. Changes of brain metabolite levels after MPH were found not to be statistically significantly different between the subtypes. The increase of choline levels after MPH compared to the levels of choline before MPH in striatum in the combined type patients were statistically significant. No clear association was found between ADHD subtypes and changes of brain metabolites with use of MPH in adult ADHD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:188 / 192
页数:5
相关论文
共 50 条
  • [21] Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy
    Gonzalez-Heydrich, Joseph
    Whitney, Jane
    Waber, Deborah
    Forbes, Peter
    Hsin, Olivia
    Faraone, Stephen V.
    Dodds, Alice
    Rao, Sneha
    Mrakotsky, Christine
    MacMillan, Carlene
    DeMaso, David R.
    de Moor, Carl
    Torres, Alcy
    Bourgeois, Blaise
    Biederman, Joseph
    EPILEPSY & BEHAVIOR, 2010, 18 (03) : 229 - 237
  • [22] Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
    Golubchik, Pavel
    Sever, Jonathan
    Weizman, Abraham
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (04) : 212 - 215
  • [23] Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
    Valdizan-Uson, J. R.
    Canovas-Martinez, A.
    De Lucas-Taracena, M. T.
    Diaz-Atienza, F.
    Eddy-Ives, L. S.
    Fernandez-Jaen, A.
    Fernandez-Perez, M.
    Garcia-Giral, M.
    Garcia-Magan, P.
    Garraus-Oneca, M.
    Idiazabal-Alecha, M. A.
    Lopez-Benito, M.
    Lorenzo-Sanz, G.
    Martinez-Anton, J.
    Martinez-Granero, M. A.
    Montanes-Rada, F.
    Mulas-Delgado, F.
    Ochando-Perales, G.
    Ortega-Garcia, E.
    Pelaz-Antolin, A.
    Ramos-Quiroga, J. A.
    Ruiz-Sanz, F. C.
    Vaquerizo-Madrid, J.
    Yusta-Izquierdo, A.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 211 - 218
  • [24] A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study
    Hegvik, Tor-Arne
    Jacobsen, Kaya Kvarme
    Fredriksen, Mats
    Zayats, Tetyana
    Haavik, Jan
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (08) : 859 - 865
  • [25] Short-TE proton magnetic resonance spectroscopy investigation in adolescents with attention-deficit hyperactivity disorder
    Yang, Pinchen
    Wu, Ming-Ting
    Dung, Shih-Shan
    Ko, Cheng-Wen
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2010, 181 (03) : 199 - 203
  • [26] Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
    Arnett, Anne B.
    Rutter, Tara M.
    Stein, Mark A.
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [27] H1-MR-spectroscopy of cerebellum in adult attention deficit/hyperactivity disorder
    Perlov, E.
    van Elst, L. Tebarzt
    Buechert, M.
    Maier, S.
    Matthies, S.
    Ebert, D.
    Hesslinger, B.
    Philipsen, A.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2010, 44 (14) : 938 - 943
  • [28] Methylphenidate Treatment and Dyskinesia in Children with Attention-Deficit/Hyperactivity Disorder
    Balazs, Judit
    Dallos, Gyoengyver
    Kereszteny, Agnes
    Czobor, Pal
    Gadoros, Julia
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (02) : 133 - 138
  • [29] An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/hyperactivity disorder
    Froelich, Jan
    Banaschewski, Tobias
    Doepfner, Manfred
    Goertz-Dorten, Anja
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (08) : 1169 - 1183
  • [30] Progression of symptoms in children with attention deficit and hyperactivity disorder in treatment with methylphenidate
    Rodriguez Hernandez, Pedro J.
    Betancort Montesinos, Moises
    Penate Castro, Wenceslao
    MEDICINA-BUENOS AIRES, 2020, 80 : 72 - 75